Korean J Physiol Pharmacol.  2000 Oct;4(5):379-383.

Diminished vascular guanylyl cyclase activity in deoxycorticosterone acetate-salt hypertension

• Lee JU
• Hong JH

Abstract

Pathophysiological implications of the vascular nitric oxide (NO)/cGMP pathway in hypertension were investigated. Sprague-Dawley rats were made deoxycorticosterone acetate (DOCA)-salt hypertensive for six weeks. The protein expression of endothelial constitutive NO synthase (ecNOS) and the tissue content of NO were determined in the thoracic aorta. The protein expression and catalytic activity of soluble guanylyl cyclase (GC) were also determined. Systolic blood pressure measured on the day of experiment was significantly higher in the experimental group than in the control. The hypertension was associated with decreases in the vascular tissue content of NO metabolites, concomitantly with the expression of ecNOS proteins. The protein expression of GC was not affected, while its catalytic activity was significantly decreased in hypertension. These results indicate that the high blood pressure is associated with a decreased activity of vascular NO/cGMP pathway in DOCA-salt hypertension.

MeSH Terms

Aorta, Thoracic
Blood Pressure
Desoxycorticosterone*
Guanylate Cyclase*
Hypertension*
Nitric Oxide
Nitric Oxide Synthase
Rats, Sprague-Dawley
Desoxycorticosterone
Guanylate Cyclase
Nitric Oxide
Nitric Oxide Synthase